Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Antibiotics - Global Market Outlook (2020-2028)

Published by Stratistics Market Research Consulting Product code 1004554
Published Content info 150+ Pages
Delivery time: 2-3 business days
Price
Back to Top
Antibiotics - Global Market Outlook (2020-2028)
Published: April 1, 2021 Content info: 150+ Pages
Description

According to Stratistics MRC, the Global Antibiotics Market is accounted for $40.70 billion in 2020 and is expected to reach $67.36 billion by 2028 growing at a CAGR of 6.5% during the forecast period. The rising prevalence of infectious diseases, supportive government legislation and the expanding vulnerable aging population are driving the market growth. However, some issues associated with antibiotics, such as antibiotic resistance and lengthy and tedious regulatory procedures is hampering the growth of the market.

Antibiotic is a medication used to either inhibit or prevent bacterial infections referred as bactericidal and bacteriostatic antibiotics, respectively. Various types of antibiotics such as penicillin, cephalosporin, carbapenem, and monobactam are available in pharmacies and hospitals that are used to treat infectious diseases.

Based on the drug class, the penicillin segment is going to have lucrative growth during the forecast period due to maximum prescription and the largest number of generic manufacturers in the space. By geography, Asia Pacific is going to have high growth during the forecast period owing to the high consumption of antibiotics, increase in the prevalence of infectious diseases, and rising government initiatives to develop novel therapies to treat drug-resistant infections in the region.

Some of the key players profiled in the Antibiotics Market include Abbott Laboratories, AbbVie Inc., Astellas Pharma, AstraZeneca Plc, Bayer AG, Daiichi Sankyo, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Melinta Therapeutics Inc., Merck KGaA, Pfizer Inc. and Sanofi.

Action Mechanisms Covered:

  • Bacteriostatic
  • Bactericidal

Inhibitors Covered:

  • Cell Wall Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • Mycolic Acid Inhibitors
  • Protein Synthesis Inhibitors
  • RNA Synthesis Inhibitors

Spectrums Covered:

  • Broad Spectrum
  • Narrow Spectrum

Route of Administrations Covered:

  • Inhalation
  • Intravenous
  • Oral
  • Parenteral
  • Sublingual
  • Topical

Indications Covered:

  • Blood Stream Infections
  • Clostridium Difficile Infections
  • Intra-Abdominal Infections
  • Urinary Tract Infection

Origins Covered:

  • Natural
  • Semisynthetic
  • Synthetic

Drug Classes Covered:

  • 7-ACA
  • Aminoglycoside
  • Beta Lactam &Beta Lactamase Inhibitors
  • Carbapenem
  • Cephalosporin
  • Fluoroquinolone
  • Imidazole
  • Lincosamide
  • Macrolide
  • Monoclonal Antibodies
  • Penicillin
  • Phenicols
  • Quinolone/Fluoroquinolone
  • Sulfonamide
  • Tetracycline

Applications Covered:

  • Human
  • Veterinary

End Users Covered:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Research Organizations

Distribution Channels Covered:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Antibiotics Market, By Action Mechanism

  • 5.1 Introduction
  • 5.2 Bacteriostatic
  • 5.3 Bactericidal

6 Global Antibiotics Market, By Inhibitor

  • 6.1 Introduction
  • 6.2 Cell Wall Synthesis Inhibitors
  • 6.3 DNA Synthesis Inhibitors
  • 6.4 Mycolic Acid Inhibitors
  • 6.5 Protein Synthesis Inhibitors
  • 6.6 RNA Synthesis Inhibitors

7 Global Antibiotics Market, By Spectrum

  • 7.1 Introduction
  • 7.2 Broad Spectrum
  • 7.3 Narrow Spectrum

8 Global Antibiotics Market, By Route of Administration

  • 8.1 Introduction
  • 8.2 Inhalation
  • 8.3 Intravenous
  • 8.4 Oral
  • 8.5 Parenteral
  • 8.6 Sublingual
  • 8.7 Topical

9 Global Antibiotics Market, By Indication

  • 9.1 Introduction
  • 9.2 Blood Stream Infections
  • 9.3 Clostridium Difficile Infections
  • 9.4 Intra-Abdominal Infections
  • 9.5 Urinary Tract Infection

10 Global Antibiotics Market, By Origin

  • 10.1 Introduction
  • 10.2 Natural
  • 10.3 Semisynthetic
  • 10.4 Synthetic

11 Global Antibiotics Market, By Drug Class

  • 11.1 Introduction
  • 11.2 7-ACA
  • 11.3 Aminoglycoside
  • 11.4 Beta Lactam &Beta Lactamase Inhibitors
  • 11.5 Carbapenem
  • 11.6 Cephalosporin
  • 11.7 Fluoroquinolone
  • 11.8 Imidazole
  • 11.9 Lincosamide
  • 11.10 Macrolide
  • 11.11 Monoclonal Antibodies
  • 11.12 Penicillin
  • 11.13 Phenicols
  • 11.14 Quinolone/Fluoroquinolone
  • 11.15 Sulfonamide
  • 11.16 Tetracycline

12 Global Antibiotics Market, By Application

  • 12.1 Introduction
  • 12.2 Human
  • 12.3 Veterinary

13 Global Antibiotics Market, By End User

  • 13.1 Introduction
  • 13.2 Hospitals
  • 13.3 Homecare
  • 13.4 Specialty Clinics
  • 13.5 Research Organizations

14 Global Antibiotics Market, By Distribution Channel

  • 14.1 Introduction
  • 14.2 Hospital Pharmacy
  • 14.3 Online Pharmacy
  • 14.4 Retail Pharmacy

15 Global Antibiotics Market, By Geography

  • 15.1 Introduction
  • 15.2 North America
    • 15.2.1 US
    • 15.2.2 Canada
    • 15.2.3 Mexico
  • 15.3 Europe
    • 15.3.1 Germany
    • 15.3.2 UK
    • 15.3.3 Italy
    • 15.3.4 France
    • 15.3.5 Spain
    • 15.3.6 Rest of Europe
  • 15.4 Asia Pacific
    • 15.4.1 Japan
    • 15.4.2 China
    • 15.4.3 India
    • 15.4.4 Australia
    • 15.4.5 New Zealand
    • 15.4.6 South Korea
    • 15.4.7 Rest of Asia Pacific
  • 15.5 South America
    • 15.5.1 Argentina
    • 15.5.2 Brazil
    • 15.5.3 Chile
    • 15.5.4 Rest of South America
  • 15.6 Middle East & Africa
    • 15.6.1 Saudi Arabia
    • 15.6.2 UAE
    • 15.6.3 Qatar
    • 15.6.4 South Africa
    • 15.6.5 Rest of Middle East & Africa

16 Key Developments

  • 16.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 16.2 Acquisitions & Mergers
  • 16.3 New Product Launch
  • 16.4 Expansions
  • 16.5 Other Key Strategies

17 Company Profiling

  • 17.1 Abbott Laboratories
  • 17.2 AbbVie Inc.
  • 17.3 Astellas Pharma
  • 17.4 AstraZeneca Plc
  • 17.5 Bayer AG
  • 17.6 Daiichi Sankyo
  • 17.7 F. Hoffmann-La Roche Ltd.
  • 17.8 Johnson & Johnson
  • 17.9 Mayne Pharma Group Ltd.
  • 17.10 Melinta Therapeutics Inc.
  • 17.11 Merck KGaA
  • 17.12 Pfizer Inc.
  • 17.13 Sanofi

List of Tables

  • Table 1 Global Antibiotics Market Outlook, By Region (2019-2028) ($MN)
  • Table 2 Global Antibiotics Market Outlook, By Action Mechanism (2019-2028) ($MN)
  • Table 3 Global Antibiotics Market Outlook, By Bacteriostatic (2019-2028) ($MN)
  • Table 4 Global Antibiotics Market Outlook, By Bactericidal (2019-2028) ($MN)
  • Table 5 Global Antibiotics Market Outlook, By Inhibitor (2019-2028) ($MN)
  • Table 6 Global Antibiotics Market Outlook, By Cell Wall Synthesis Inhibitors (2019-2028) ($MN)
  • Table 7 Global Antibiotics Market Outlook, By DNA Synthesis Inhibitors (2019-2028) ($MN)
  • Table 8 Global Antibiotics Market Outlook, By Mycolic Acid Inhibitors (2019-2028) ($MN)
  • Table 9 Global Antibiotics Market Outlook, By Protein Synthesis Inhibitors (2019-2028) ($MN)
  • Table 10 Global Antibiotics Market Outlook, By RNA Synthesis Inhibitors (2019-2028) ($MN)
  • Table 11 Global Antibiotics Market Outlook, By Spectrum (2019-2028) ($MN)
  • Table 12 Global Antibiotics Market Outlook, By Broad Spectrum (2019-2028) ($MN)
  • Table 13 Global Antibiotics Market Outlook, By Narrow Spectrum (2019-2028) ($MN)
  • Table 14 Global Antibiotics Market Outlook, By Route of Administration (2019-2028) ($MN)
  • Table 15 Global Antibiotics Market Outlook, By Inhalation (2019-2028) ($MN)
  • Table 16 Global Antibiotics Market Outlook, By Intravenous (2019-2028) ($MN)
  • Table 17 Global Antibiotics Market Outlook, By Oral (2019-2028) ($MN)
  • Table 18 Global Antibiotics Market Outlook, By Parenteral (2019-2028) ($MN)
  • Table 19 Global Antibiotics Market Outlook, By Sublingual (2019-2028) ($MN)
  • Table 20 Global Antibiotics Market Outlook, By Topical (2019-2028) ($MN)
  • Table 21 Global Antibiotics Market Outlook, By Indication (2019-2028) ($MN)
  • Table 22 Global Antibiotics Market Outlook, By Blood Stream Infections (2019-2028) ($MN)
  • Table 23 Global Antibiotics Market Outlook, By Clostridium Difficile Infections (2019-2028) ($MN)
  • Table 24 Global Antibiotics Market Outlook, By Intra-Abdominal Infections (2019-2028) ($MN)
  • Table 25 Global Antibiotics Market Outlook, By Urinary Tract Infection (2019-2028) ($MN)
  • Table 26 Global Antibiotics Market Outlook, By Origin (2019-2028) ($MN)
  • Table 27 Global Antibiotics Market Outlook, By Natural (2019-2028) ($MN)
  • Table 28 Global Antibiotics Market Outlook, By Semisynthetic (2019-2028) ($MN)
  • Table 29 Global Antibiotics Market Outlook, By Synthetic (2019-2028) ($MN)
  • Table 30 Global Antibiotics Market Outlook, By Drug Class (2019-2028) ($MN)
  • Table 31 Global Antibiotics Market Outlook, By 7-ACA (2019-2028) ($MN)
  • Table 32 Global Antibiotics Market Outlook, By Aminoglycoside (2019-2028) ($MN)
  • Table 33 Global Antibiotics Market Outlook, By Beta Lactam &Beta Lactamase Inhibitors (2019-2028) ($MN)
  • Table 34 Global Antibiotics Market Outlook, By Carbapenem (2019-2028) ($MN)
  • Table 35 Global Antibiotics Market Outlook, By Cephalosporin (2019-2028) ($MN)
  • Table 36 Global Antibiotics Market Outlook, By Fluoroquinolone (2019-2028) ($MN)
  • Table 37 Global Antibiotics Market Outlook, By Imidazole (2019-2028) ($MN)
  • Table 38 Global Antibiotics Market Outlook, By Lincosamide (2019-2028) ($MN)
  • Table 39 Global Antibiotics Market Outlook, By Macrolide (2019-2028) ($MN)
  • Table 40 Global Antibiotics Market Outlook, By Monoclonal Antibodies (2019-2028) ($MN)
  • Table 41 Global Antibiotics Market Outlook, By Penicillin (2019-2028) ($MN)
  • Table 42 Global Antibiotics Market Outlook, By Phenicols (2019-2028) ($MN)
  • Table 43 Global Antibiotics Market Outlook, By Quinolone/Fluoroquinolone (2019-2028) ($MN)
  • Table 44 Global Antibiotics Market Outlook, By Sulfonamide (2019-2028) ($MN)
  • Table 45 Global Antibiotics Market Outlook, By Tetracycline (2019-2028) ($MN)
  • Table 46 Global Antibiotics Market Outlook, By Application (2019-2028) ($MN)
  • Table 47 Global Antibiotics Market Outlook, By Human (2019-2028) ($MN)
  • Table 48 Global Antibiotics Market Outlook, By Veterinary (2019-2028) ($MN)
  • Table 49 Global Antibiotics Market Outlook, By End User (2019-2028) ($MN)
  • Table 50 Global Antibiotics Market Outlook, By Hospitals (2019-2028) ($MN)
  • Table 51 Global Antibiotics Market Outlook, By Homecare (2019-2028) ($MN)
  • Table 52 Global Antibiotics Market Outlook, By Specialty Clinics (2019-2028) ($MN)
  • Table 53 Global Antibiotics Market Outlook, By Research Organizations (2019-2028) ($MN)
  • Table 54 Global Antibiotics Market Outlook, By Distribution Channel (2019-2028) ($MN)
  • Table 55 Global Antibiotics Market Outlook, By Hospital Pharmacy (2019-2028) ($MN)
  • Table 56 Global Antibiotics Market Outlook, By Online Pharmacy (2019-2028) ($MN)
  • Table 57 Global Antibiotics Market Outlook, By Retail Pharmacy (2019-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Back to Top